These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cost-effectiveness of atypical antipsychotics in chronic schizophrenia.
    Author: Amin S.
    Journal: Hosp Med; 1999 Jun; 60(6):410-3. PubMed ID: 10492711.
    Abstract:
    It is nearly a decade since the first atypical antipsychotic, clozapine, was launched in the UK. There are now several other similar drugs on the market. They are all more expensive than traditional antipsychotics and the question of whether they are a cost-effective use of scare NHS resources is an important one. This article reviews the evidence in the area of treatment-resistant schizophrenia.
    [Abstract] [Full Text] [Related] [New Search]